IXICO Mission

To transform the advancement of investigational therapies for neurological diseases

Our Mission

Since 2004, we have been dedicated to delivering insights in neuroscience. Our mission is to transform the advancement of new therapies for neurological diseases through the application of medical image analysis and digital health technologies, bringing safe and effective treatment to patients sooner. We are committed to advancing imaging biomarkers in CNS therapeutic areas such as Huntington’s disease, Parkinson’s disease and Alzheimer’s disease. 

Alzheimer’s disease, for example, affects over 50 million people worldwide with devastating emotional and financial impact on patients and families. With no disease modifying therapies and 99.6% failure rate in drug development, Alzheimer’s disease remains an acute area of unmet need in clinical research. IXICO teams are relentlessly focused on advancing medicine and human health through cutting edge neuroscience and breakthrough AI technologies to support potential therapies in neurological and neurodegenerative disorders. 

Our Guiding Principles

Expertise

We are specialist experts in neuroimaging data analysis. We are continually recruiting the best minds in the industry whose knowledge is at the cutting edge of clinical and technology advancement.

Innovation

We never stop striving to innovate, improve and advance clinical research into neurodegenerative diseases. Our greatest assets are the talented people who are continually developing, evolving, and deploying our innovative AI and digital technologies.

Quality

Our commitment to the highest standards drives our operational excellence. We ensure everything we do is fully backed by utmost quality and compliance. We support our people to be the best they can be through continuous learning and development.

Integrity

We conduct our business to the highest ethical standards and aim to be the trusted partner of choice for CNS clinical trials. We pride ourselves on the strong relationships we build with our clients as well as the exceptional work we deliver.

Our Company Story

Top timeline logo

2019

King's College Partnership

IXICO was chosen as partner for King's College London's UK Government-funded Medical Imaging & Artificial Intelligence Centre

2018

Product Investment

Oversubscribed placing of £5.5m to invest in new product and new market development

2017

Digital biomarkers commercial collaboration

The arrival of connected digital technologies (wearable biosensors and mobile devices) that enable the passive measurement of parameters such as sleep, activity and heart rate outside of the clinic, has provided the opportunity to revolutionize the capture of data in clinical trials.

READ MORE about Innovation at IXICO

2015

Post-marketing surveillance commercial collaboration

IXICO are partnering with pharma companies to develop digital clinical decision support technologies based on our Assessa platform technology to improve the targeting and the safety and effectiveness of their therapeutics.

2014

Assessa platform launched

The clinical decision support platform, Assessa provides access to expert neuroradiologists for a standardized radiological read, and securely captures then transfers clinical data and MR images from referring neurologists to expert neuroradiologists.

 

 

2013

AIM listing

IXICO was listed on the Alternative Investment Market (AIM), a sub-market of the London Stock Exchange (LSE).

2008

Web-based TrialTracker platform launched

The TrialTrackerTM data managment platform is a secure and compliant environment for the collection, analysis and interpretation of large image files and other data that may be generated in the course of a clinical study.

2007

First Phase 3 trial

IXICO is awarded it's first Phase 3 study for Alzheimer's disease.

2006

Clinical trial platform launched

IXICO provides neuroscience expertise and global operations to deliver imaging and digital biomarker analytical services for clinical development, within a framework of regulatory compliance.

2004

IXICO founded

A spin-out from London universities' ‘Information eXtraction from Images’ project.

Collaborations

Collaboration within clinical research is key to advancing treatments for neurological diseases. Working with partners in academia, business and charitable organisations, we help further the international scientific and regulatory agenda. We provide access to our platform and advanced data analysis for more accurate and applicable insights that further neurological research. We are also working with partners to develop new analytical techniques and digital health products to improve patient outcomes.

Read more

Work with us

Careers at IXICO

Our team of scientists, researchers, quality professionals, and business people are passionate about their role in advancing neurological research – it’s what gets us out of bed. We work with incredible partners in biopharmaceuticals, academic institutions and clinical research sites around the world. Are you an innovator on the cutting edge of clinical research and technologies? Get in touch today. 

View our vacancies